RxDoctor Payments Data

Selina James, MD

Internal Medicine · Raleigh, NCNPI 1447236781

Payments from drug & device makers

$6,710in general payments, 2019–2025

Across 452 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Amgen$732
  • Lilly USA, LLC$522
  • AstraZeneca$454
  • AbbVie$449
  • Boehringer Ingelheim$342
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$6,691100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,710 in reported general payments places this provider in the 90th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$108,994
Medicare patients
231
Services billed
1,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin60$68,490
OzempicSemaglutide49$63,106
MounjaroTirzepatide37$37,073
EliquisApixaban22$27,291
RybelsusSemaglutide16$24,551
TrulicityDulaglutide16$19,455
XareltoRivaroxaban26$17,521
SynthroidLevothyroxine Sodium112$12,611
MyrbetriqMirabegron11$6,347
Rosuvastatin Calcium380$5,126
Buprenorphine12$3,645
Pravastatin Sodium153$3,550
Levothyroxine Sodium260$3,037
Atorvastatin Calcium288$2,661
Gabapentin155$2,396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,793$87,65765 claims
Boehringer IngelheimJardiance$342$68,49060 claims
Lilly USA, LLCMounjaro, Trulicity$522$56,52853 claims
PfizerEliquis$190$27,29122 claims
Johnson & JohnsonXarelto$232$17,52126 claims
AbbVieSynthroid$449$12,611112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,302 internal medicine providers in North Carolina.

Other internal medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →